Innovative MYRRHA Research Reactor

The Challenge

The MYRRHA project, a pioneering initiative to develop the world’s first high-power research reactor driven by a particle accelerator, presents a significant challenge. This ambitious project aims to reduce nuclear waste and produce medical radioisotopes for innovative cancer treatments. The complexity of designing and constructing such a unique and versatile research infrastructure requires advanced engineering solutions and meticulous planning to ensure its success.

The Solution

Tractebel responds to this challenge by providing EPCM (Engineering, Procurement, Construction Management) services for the design and construction of the buildings and auxiliary systems of the 100 MeV MINERVA proton accelerator. Their approach includes developing a comprehensive and integrated design that leverages cutting-edge technology to meet the project’s ambitious goals. Tractebel’s engineers have been involved from the very beginning, ensuring that every aspect of the project aligns with the stakeholders‘ vision and regulatory requirements.

The Impact

Tractebel’s involvement in the MYRRHA project has led to the creation of a groundbreaking research reactor that significantly advances nuclear science and medicine. Their innovative solutions have enabled the production of theranostic radioisotopes for targeted cancer treatments, reducing side effects for patients. Additionally, the project contributes to the reduction of nuclear waste, promoting a more sustainable approach to nuclear energy. This transformative impact underscores Tractebel’s commitment to pioneering advancements in engineering and technology.